This inventor holds 5 USPTO granted patents and 2 EPO patents. Top assignees: Georgetown University, University of Illinois. Active years: 2010-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Rockville, MD (US) (2010)
- Naperville, IL (US) (2012 - 2014)
- Chicago, IL (US) (2015)
Company Filing History:
4 out of 499 
2 out of 2,432 
Years Active: 2010-2015
Title: The Innovative Contributions of Pavel A. Petukhov
Introduction: Pavel A. Petukhov is a distinguished inventor based in Naperville, IL, with an impressive portfolio consisting of five patents. His work primarily focuses on the development of novel pharmaceuticals aimed at addressing significant health challenges, particularly in oncology and neurology.
Latest Patents: Among Pavel's most recent patents are two notable innovations that greatly advance the field of cancer treatment. The first patent, titled "Photoreactive Benzamide Probes for Histone Deacetylase 2," details the design, modeling, synthesis, biological evaluation, and photoaffinity labeling studies of a series of photoreactive, potent, and selective HDACs 1 and 2 benzamide-based probes. This innovation promises to enhance the understanding of histone deacetylase functions in cellular processes. The second patent, "Histone Deacetylase Inhibitors and Methods of Use Thereof," offers novel classes of HDAC inhibitors, along with methods to sensitize cancer cells to the cytotoxic effects of radiotherapy. It also includes methods for treating cancer and neurological diseases, as well as comprehensive pharmaceutical compositions and kits containing these HDAC inhibitors.
Career Highlights: Pavel A. Petukhov's career has been marked by his association with prestigious institutions, notably Georgetown University and the University of Illinois. His tenure at these universities has enabled him to contribute significantly to research, especially in the fields of pharmaceuticals and medical advancements.
Collaborations: Throughout his career, Pavel has collaborated with esteemed colleagues such as Anatoly Dritschilo and Mira Jung. These partnerships have enhanced the development and fine-tuning of his inventive concepts, furthering the impact of his work in the scientific community.
Conclusion: Pavel A. Petukhov's contributions to innovation, particularly in the realm of HDAC inhibitors and cancer treatment methods, showcase his commitment to addressing important medical challenges. With a solid foundation of patents and a history of fruitful collaborations, he remains a key figure in the field of pharmaceutical sciences.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile